Briefing

Featured article

UK government targets manufacturing as it eyes £41bn life science sector growth

Also in this section

News in Numbers

Latest News

Latest Deals

07/23/2025 13:30:52
  • Home | Can rare disease research in the US thrive under the GOP?
  • Editor's letter
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Syngene Company Insight
  • Briefing
  • News in Numbers
  • Latest News
  • Latest Deals
  • Nipro
  • In Depth
  • Can rare disease research in the US thrive under the new administration?
  • Protocol flexibility and navigating the US geopolitical landscape in oncology clinical trials
  • EU’s Pharma Package falls short of Europe’s goal of global competitiveness
  • How will RFK Jr’s American dream for vaccines play out?
  • From discovery to delivery: making therapies reach patients faster
  • ADCs on the rise: US manufacturing funding grows
  • AAPS
  • Listings
  • Events
  • Excellence Awards
  • Buyer's Guides
  • Next issue
07/23/2025 00:00:00